Cargando…

Drugs inducing T-cell mediated cutaneous adverse reactions and contact sensitizers evoke similar responses in THP-1 cells

Detalles Bibliográficos
Autores principales:	Gonçalo, Margarida, Martins, João, Silva, Ana, Neves, Bruno, Cruz, Teresa, Lopes, Celeste
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128176/ http://dx.doi.org/10.1186/2045-7022-4-S3-P50

Ejemplares similares

Nature and kinetics of redox imbalance triggered by respiratory and skin chemical sensitizers on the human monocytic cell line THP-1
por: Ferreira, Isabel, et al.
Publicado: (2018)

Overlap between maculopapular exanthema and DRESS among cutaneous adverse drug reactions in a dermatology ward (2008-2012)
por: Gouveia, Miguel Pinto, et al.
Publicado: (2014)

ADVERSE CUTANEOUS DRUG REACTION
por: Nayak, Surajit, et al.
Publicado: (2008)

Cutaneous Adverse Reactions of Amiodarone
por: Jaworski, Krzysztof, et al.
Publicado: (2014)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Analysis of B cell subsets in severe cutaneous adverse reaction
por: Azukizawa, Hiroaki, et al.
Publicado: (2014)

Treatments for Severe Cutaneous Adverse Reactions
por: Cho, Yung-Tsu, et al.
Publicado: (2017)

Epidemiology of cutaneous adverse drug reactions
por: Mockenhaupt, M.
Publicado: (2017)

Genetics of Severe Cutaneous Adverse Reactions
por: Yang, Shang-Chen, et al.
Publicado: (2021)

Morphine‐induced cutaneous adverse drug reaction following occupational diacetylmorphine contact dermatitis: A case report
por: van den Hoed, Ewoud, et al.
Publicado: (2019)

Mobile apps for quick adverse drug reaction report: A scoping review
por: Parracha, Edna Ribeiro, et al.
Publicado: (2022)

Dexamethasone prevents granulocyte-macrophage colony-stimulating factor-induced nuclear factor-kappaB activation, inducible nitric oxide synthase expression and nitric oxide production in a skin dendritic cell line.
por: Vital, Ana Luísa, et al.
Publicado: (2003)

Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?
por: Diogo, Patrícia, et al.
Publicado: (2022)

Causality Assessment of Cutaneous Adverse Drug Reactions
por: Son, Young-Min, et al.
Publicado: (2011)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Unusual and Interesting Adverse Cutaneous Drug Reactions
por: Masatkar, Vaishali, et al.
Publicado: (2018)

Controversies in the Management of Cutaneous Adverse Drug Reactions
por: Manchanda, Yashpal, et al.
Publicado: (2018)

Genetic markers of severe cutaneous adverse reactions
por: Jung, Jae-Woo, et al.
Publicado: (2018)

The assessment of severe cutaneous adverse drug reactions
por: Copaescu, Ana M, et al.
Publicado: (2022)

Chemokines in Severe Cutaneous Adverse Reactions (SCARs)
por: Miyagawa, Fumi, et al.
Publicado: (2021)

Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Rossi, Gabriela, et al.
Publicado: (2021)

Vancomycin-Associated Spontaneous Cutaneous Adverse Drug Reactions
por: An, So-Yeon, et al.
Publicado: (2011)

Immunohistopathological Findings of Severe Cutaneous Adverse Drug Reactions
por: Orime, Mari
Publicado: (2017)

Recent Advances in Severe Cutaneous Adverse Drug Reaction
por: Das, Sudip, et al.
Publicado: (2018)

An Update on Adverse Cutaneous Drug Reactions in HIV/AIDS
por: Hoosen, Koraisha, et al.
Publicado: (2019)

Cutaneous Adverse Reactions Associated with COVID-19 Vaccination
por: Jin, Hope, et al.
Publicado: (2023)

Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma
por: Nikolaou, Vasiliki, et al.
Publicado: (2023)

Release of IL-1β via IL-1β-Converting Enzyme in a Skin Dendritic Cell Line Exposed to 2,4-Dinitrofluorobenzene
por: Matos, Teresa J., et al.
Publicado: (2005)

Multiple drug hypersensitivity associated with severe cutaneous adverse reaction
por: Lin Choo, Karen Jui, et al.
Publicado: (2014)

Cytotoxic Proteins and Therapeutic Targets in Severe Cutaneous Adverse Reactions
por: Su, Shih-Chi, et al.
Publicado: (2014)

Cutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic Drugs
por: Koch, Tina, et al.
Publicado: (2016)

Severe Cutaneous Adverse Drug Reactions: A Clinicoepidemiological Study
por: Sasidharanpillai, Sarita, et al.
Publicado: (2015)

Probable cutaneous adverse drug reaction to piroxicam in a cat
por: Young, Amanda J, et al.
Publicado: (2018)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Severe Cutaneous Adverse Reaction (SCAR): Clinical Pharmacologists’ Viewpoint
por: Shafiq, Nusrat, et al.
Publicado: (2022)

Severe Cutaneous Adverse Reactions Caused by Anti-Tubercular Drugs
por: Kim, Sang-Heon
Publicado: (2021)

A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions
por: Mencarelli, Andrea, et al.
Publicado: (2020)

Engaging narratives evoke similar neural activity and lead to similar time perception
por: Cohen, Samantha S., et al.
Publicado: (2017)

NLRP3 Inflammasome and Allergic Contact Dermatitis: A Connection to Demystify
por: Sebastião, Ana Isabel, et al.
Publicado: (2020)

Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Pan, Ren-You, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0a1re530tdpvl0uq7m3kqjf47t